OR Royalties Inc. (NYSE:OR – Get Free Report) has received a consensus recommendation of “Hold” from the nine analysts that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, three have given a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $40.50.
Several equities research analysts recently commented on the company. Weiss Ratings downgraded OR Royalties from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, July 24th. Zacks Research cut shares of OR Royalties from a “hold” rating to a “strong sell” rating in a report on Monday, July 13th. Jefferies Financial Group decreased their target price on OR Royalties from $40.00 to $34.00 and set a “hold” rating for the company in a research report on Monday, July 6th. Royal Bank Of Canada decreased their price target on shares of OR Royalties from $50.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, July 9th. Finally, Scotiabank reduced their price objective on OR Royalties from $51.00 to $42.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 14th.
View Our Latest Analysis on OR
Institutional Investors Weigh In On OR Royalties
OR Royalties Stock Performance
NYSE:OR opened at $37.52 on Thursday. The firm’s fifty day simple moving average is $31.65 and its 200 day simple moving average is $36.50. The company has a current ratio of 2.28, a quick ratio of 2.28 and a debt-to-equity ratio of 0.14. OR Royalties has a twelve month low of $27.54 and a twelve month high of $48.06. The firm has a market capitalization of $6.99 billion, a price-to-earnings ratio of 25.01 and a beta of 0.75.
OR Royalties (NYSE:OR – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The basic materials company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.01. OR Royalties had a return on equity of 16.41% and a net margin of 78.04%.The firm had revenue of $97.82 million during the quarter, compared to the consensus estimate of $97.93 million. As a group, equities research analysts expect that OR Royalties will post 1.25 earnings per share for the current fiscal year.
OR Royalties Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Wednesday, September 30th will be issued a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. OR Royalties’s dividend payout ratio is 16.67%.
About OR Royalties
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Featured Stories
- Five stocks we like better than OR Royalties
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
